Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
PASG on Nasdaq
Shares outstanding
3,182,163
Price per share
$8.03
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
87,426
Total reported value
$702,031
Share change
-32,555,270
Value change
-$13,025,707
Number of holders
1
Price from insider filings
$8.03
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Erste Asset Management GmbH 4.4% -20% $859,530 -$176,750 2,455,800 -17% Erste Asset Management GmbH 31 Mar 2024
Lynx1 Capital Management LP 20% +31% $205,822 -$2,848,972 623,704 -93% LYNX1 CAPITAL MANAGEMENT LP 30 Sep 2025
ORBIMED ADVISORS LLC 4.2% -45% $43,716 -$36,764 132,473 -46% ORBIMED ADVISORS LLC 22 Jul 2025

As of 30 Sep 2025, 1 institutional investors reported holding 87,426 shares of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG). This represents 2.7% of the company’s total 3,182,163 outstanding shares.

Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 87,426 $702,031 -$13,025,707 $8.03 1
2025 Q2 32,555,495 $13,025,837 -$494,595 $0.40 36
2025 Q1 36,319,532 $12,823,290 -$494,943 $0.35 40
2024 Q4 37,629,720 $21,576,769 -$666,123 $0.57 43
2024 Q3 38,667,151 $27,063,599 -$1,516,418 $0.70 43
2024 Q2 40,276,764 $31,993,150 -$250,682 $0.79 41
2024 Q1 40,303,060 $54,404,729 +$10,301,382 $1.35 48
2023 Q4 2,960,800 $2,990,408 +$606,000 $1.01 1
2023 Q3 100 $1,000 -$139,557 $10.00 1
2023 Q2 31,198,174 $29,354,477 -$2,631,665 $0.94 51
2023 Q1 33,975,602 $32,533,235 -$2,407,138 $0.96 53
2022 Q4 35,807,659 $49,406,962 -$1,871,558 $1.38 62
2022 Q3 37,683,440 $47,102,000 -$3,931,122 $1.25 60
2022 Q2 39,916,391 $94,162,035 -$2,838,274 $2.36 71
2022 Q1 41,574,196 $128,878,040 -$494,425 $3.10 95
2021 Q4 41,029,975 $260,551,958 -$25,131,733 $6.35 90
2021 Q3 42,080,753 $419,127,083 -$30,001,811 $9.96 99
2021 Q2 38,993,325 $516,277,406 -$7,521,445 $13.24 98
2021 Q1 44,970,326 $786,069,406 +$224,036,560 $17.48 86
2020 Q4 31,980,406 $817,764,848 +$42,142,423 $25.57 70
2020 Q3 30,775,951 $403,487,177 -$23,840,648 $13.11 66
2020 Q2 26,830,579 $732,341,732 +$35,922,794 $27.33 65
2020 Q1 29,151,958 $458,206,000 +$457,417,972 $15.75 45